Unigestion Holding SA decreased its position in shares of Clorox Co (NYSE:CLX) by 11.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 165,521 shares of the company’s stock after selling 21,386 shares during the quarter. Unigestion Holding SA’s holdings in Clorox were worth $25,514,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vaughan David Investments LLC IL lifted its holdings in shares of Clorox by 4.7% in the fourth quarter. Vaughan David Investments LLC IL now owns 2,341 shares of the company’s stock worth $361,000 after acquiring an additional 106 shares during the last quarter. Old North State Trust LLC lifted its holdings in shares of Clorox by 41.9% in the fourth quarter. Old North State Trust LLC now owns 1,755 shares of the company’s stock worth $270,000 after acquiring an additional 518 shares during the last quarter. Norinchukin Bank The lifted its holdings in shares of Clorox by 3.7% in the fourth quarter. Norinchukin Bank The now owns 130,715 shares of the company’s stock worth $20,149,000 after acquiring an additional 4,640 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in shares of Clorox by 23.1% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 40,391 shares of the company’s stock worth $6,141,000 after acquiring an additional 7,580 shares during the last quarter. Finally, Mission Wealth Management LP lifted its holdings in shares of Clorox by 4.4% in the fourth quarter. Mission Wealth Management LP now owns 3,848 shares of the company’s stock worth $593,000 after acquiring an additional 163 shares during the last quarter. 77.90% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently issued reports on CLX. Wells Fargo & Co reaffirmed a “hold” rating and issued a $157.00 price objective on shares of Clorox in a research note on Thursday. Barclays reaffirmed a “hold” rating and issued a $142.00 price objective on shares of Clorox in a research note on Wednesday, February 6th. Citigroup set a $171.00 price objective on Clorox and gave the company a “hold” rating in a research note on Tuesday, February 5th. BMO Capital Markets set a $175.00 price objective on Clorox and gave the company a “buy” rating in a research note on Tuesday, February 5th. Finally, Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $149.08.
NYSE:CLX traded up $0.38 on Friday, reaching $159.32. 13,972 shares of the stock traded hands, compared to its average volume of 1,138,989. The company has a market capitalization of $19.90 billion, a PE ratio of 25.44, a P/E/G ratio of 3.86 and a beta of 0.29. The company has a debt-to-equity ratio of 3.08, a quick ratio of 0.66 and a current ratio of 1.15. Clorox Co has a 1-year low of $113.57 and a 1-year high of $167.70.
Clorox (NYSE:CLX) last released its earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.32 by $0.08. The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The company’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.77 EPS. Research analysts predict that Clorox Co will post 6.33 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a yield of 2.41%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is presently 61.34%.
In other Clorox news, SVP Matthew T. Laszlo sold 10,585 shares of the stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the completion of the sale, the senior vice president now owns 17,994 shares of the company’s stock, valued at approximately $2,769,096.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Denise Garner sold 18,366 shares of the stock in a transaction that occurred on Friday, December 7th. The shares were sold at an average price of $163.53, for a total transaction of $3,003,391.98. Following the sale, the senior vice president now directly owns 16,241 shares of the company’s stock, valued at approximately $2,655,890.73. The disclosure for this sale can be found here. Insiders have sold a total of 236,361 shares of company stock valued at $38,700,029 in the last three months. Insiders own 1.40% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: What are trading strategies for the 52-week high/low?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.